Skip to Content

190 77 (Capecitabine 150 mg)

Pill with imprint 190 77 is Peach, Capsule-shape and has been identified as Capecitabine 150 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; anal cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 190 77

Capecitabine 150 mg 190 77
Capecitabine 150 mg 190 77
Capecitabine 150 mg 190 77
Capecitabine 150 mg 190 77

Capecitabine

Imprint:
190 77
Strength:
150 mg
Color:
Peach
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00093-7473 Teva Pharmaceuticals USA, Inc.
42291-0190 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide